ArticleOncotarget2018
A potential novel option for cancer immunotherapy - TLR7 stimulation inhibits malignant melanoma bone invasion.
Takenobu KatagiriPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it